Clinical center University of Sarajevo

What Clinical center University of Sarajevo does

Clinical Center University of Sarajevo (Klinički centar Univerziteta u Sarajevu, KCUS) is the largest and most complex tertiary healthcare institution in Bosnia and Herzegovina, founded in 1894 as Zemaljska bolnica with historical roots back to 1866. Operating under government mandate, the institution comprises more than 30 specialized clinics covering the full medical spectrum, including cardiology, cardiovascular surgery, oncology, hematology with bone marrow and stem cell transplantation, neurosurgery, gastroenterohepatology, nephrology, pediatrics, psychiatry, emergency medicine, clinical microbiology (WHO Reference Laboratory since 2012, National Influenza Center since 2017), and clinical immunology. The center functions simultaneously as a teaching base for the University of Sarajevo Medical Faculty and a clinical research site participating in international trials and European reference laboratory networks.

In 2025, KCUS delivered 525,905 outpatient examinations, 45,299 hospitalizations accounting for 275,376 hospital days, 18,516 operations, and 5,274,853 biochemical analyses, supported by more than 3,500 employees across clinical, administrative, and technical functions. The institution operates four physical sites in Sarajevo (Koševo headquarters, plus Ilidža, Jezero, and the new Central Medical Block) and is currently transitioning legacy clinics from 130+ year-old buildings into the modern Central Medical Block facility.

KCUS generates revenue through publicly funded healthcare services reimbursed by Federation of Bosnia and Herzegovina health insurance funds, supplemented by direct patient contributions and participation in clinical research. It is a state-owned institution governed by a General Director with discipline-level directors across internal medicine, surgery, diagnostics, neuropsychiatry, gynecology/obstetrics, pediatrics, and science/education. Customer concentration is high given the single-payer public funding model, though patient volume is geographically distributed across all FBiH cantons.

Name

Clinical center University of Sarajevo

Legal name

Klinički centar Univerziteta u Sarajevu

Website

https://kcus.ba

Company type

Private

Founded year

1894

Operating status

Operating

Headcount range

251–500 employees

Short description

Clinical Center University of Sarajevo (KCUS) is Bosnia and Herzegovina's largest public tertiary healthcare institution, operating 30+ specialized clinics and serving as the University of Sarajevo teaching base, delivering secondary and tertiary medical services to patients from across the Federation.

Ownership category

akta.pro rank

Product category

Tertiary Healthcare Services

NAICS

General Medical and Surgical Hospitals (6221), General Medical and Surgical Hospitals (62211), Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Specialty (except Psychiatric and Substance Abuse) Hospitals (62231)

SIC

Services-Hospitals (8060), Services-General Medical & Surgical Hospitals, Nec (8062)

akta.pro industry

PRIMARYHLAFAAAO

Hospital Shared Services, GPOs & System Support Organizations

Healthcare & Life Sciences/Healthcare Providers & Systems/Acute Care Hospitals & Health Systems

SECONDARYHLAGAEAA

Central Laboratory Services (Core Lab Operations)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)

SECONDARYHLAKANAH

Critical Care / ICU Pulmonology (Intensivist Services)

Healthcare & Life Sciences/Specialist Medical Practice/Pulmonology & Sleep Medicine

Keywords

• Tertiary healthcare services
• Specialized hospital clinics
• Medical education training
• Clinical research trials
• Emergency medical services

Headquarters

HQ city

Sarajevo

HQ country

Bosnia & Herzegovina

HQ region

Europe

Offices4 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain

Revenue model

1. Healthcare Services: As a public healthcare institution, KCUS generates revenue through government-funded healthcare services covered by health insurance. The institution provides secondary and tertiary level healthcare services to patients from all over Bosnia and Herzegovina, with services paid through health insurance funds and direct patient contributions.
2. Clinical Research: KCUS participates in international clinical studies from various medical fields, contributing to the development of modern medical practice and providing access to new therapeutic options for patients.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Core offering

KCUS is the largest and most complex public healthcare institution in Bosnia and Herzegovina, delivering secondary and tertiary healthcare services through 30+ specialized clinics covering cardiology, oncology, hematology, neurosurgery, gastroenterohepatology, pediatrics, and other medical disciplines. It also functions as the teaching base for the University of Sarajevo Medical Faculty, hosts a WHO Reference Laboratory, and participates in international clinical research.

Product overview

The Clinical Center University of Sarajevo (KCUS) is the most complex healthcare institution in Bosnia and Herzegovina, providing secondary and tertiary healthcare services through a multi-specialty hospital architecture. The organization comprises over 30 specialized clinics including Emergency Medicine, Anesthesiology, Cardiology, Neurology, Neurosurgery, Oncology, Hematology with Bone Marrow Transplantation, Gastroenterohepatology, Pediatrics, Psychiatry, and Clinical Microbiology (WHO Reference Laboratory). KCUS operates as a unified clinical services platform with supporting infrastructure including the KCUS Library with access to international databases (PubMed, Scopus, ScienceDirect, UpToDate, HINARI), two scientific journals (Medicinski Žurnal and BJHST), Clinical Research Services for international trials, and a dedicated Hemophilia Center. The institution also publishes citostatic drug availability information and maintains an electronic waiting list system.

Differentiator

Problem solved

Functional benefit

Products and services

• Secondary and Tertiary Healthcare Services
• Emergency Medicine Clinic (KUM)
• Cardiology Clinic (Heart, Blood Vessels and Rheumatism)
• Gastroenterohepatology Clinic
• Hematology Clinic with Bone Marrow Transplantation
• Hemophilia Center
• Oncology Clinic
• Cardiovascular Surgery Clinic
• Clinical Microbiology and WHO Reference Laboratory
• Clinical Immunology
• Pediatric Surgery Clinic
• Clinical Research Services
• Medicinski žurnal (Medical Journal)
• Bosnian Journal of Health Sciences and Technologies (BJHST)
• Citostatics Information System

Quantifiable outcome

• 525,905 outpatient examinations in 2025
• +6 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration9 records

Feature7 records

Partnerships

20 partnerships are on record, tiered core and minor.

• EUFOR (European Union Force)coreStrategic or Co-development Partner · 18 June 2026Cooperation for helicopter transport and rapid evacuation for saving lives of citizens. The collaboration enables emergency medical evacuation services.
• Institut Pasteur, FrancecoreStrategic or Co-development PartnerCollaboration through the MediLabSecure project (Preventing Vector Borne Diseases around the Mediterranean and Black Sea regions). Funded by the European Commission, this project aims to create a framework for cooperation to improve surveillance of vector-borne infectious diseases, biological safety, communication, and training between laboratories.
• Robert Koch Institute, BerlincoreStrategic or Co-development PartnerExternal quality control and expert assistance in microbiology and infectious disease surveillance.
• Reference Laboratory in LuxembourgcoreStrategic or Co-development PartnerExternal quality control for rash-related infectious diseases. Coordinates all activities regarding external quality control of Reference Laboratories, reagent sending, education, training, and assistance in developing standard operating procedures.
• CDC Laboratory for Influenza Surveillance, Madison, USAcoreStrategic or Co-development PartnerCollaboration through the project 'Surveillance and Response to Avian and Pandemic Influenza in Bosnia and Herzegovina' implemented by the Center for Disease Control and Prevention (CDC).
• The Francis Crick Institute, London, UKcoreStrategic or Co-development PartnerExternal quality control and expert assistance for advanced microbiological diagnostics.
• Technical University of Denmark DTU and Statens Serum Institut (SSI)coreStrategic or Co-development PartnerCollaboration through the EURGen-RefLabCap project. Bosnia and Herzegovina is recognized as a priority country for strengthening laboratory capacity for antimicrobial resistance surveillance, with Clinical Microbiology serving as the Reference Laboratory for project implementation.
• World Federation of HemophiliacoreStrategic or Co-development PartnerThe Hemophilia Center participates in the prestigious Twinning Program of the World Federation of Hemophilia for improving hemophilia care and treatment standards.
• European Hemophilia ConsortiumcoreStrategic or Co-development PartnerActive collaboration with European organizations dedicated to hemophilia treatment and research.
• European Alliance for Hemophilia and Allied DisorderscoreStrategic or Co-development PartnerActive collaboration with European organizations dedicated to hemophilia and related bleeding disorders.
• Hemophilia Association of Bosnia and HerzegovinacoreStrategic or Co-development PartnerNational collaboration with patient organization for hemophilia care.
• Alliance for Rare Diseases of FBiHcoreStrategic or Co-development PartnerCollaboration with the federation-wide alliance for rare diseases support.
• CAESAR NetworkcoreStrategic or Co-development PartnerCentral Asian and European Surveillance of Antimicrobial Resistance network. Clinical Microbiology serves as the coordinator for the Federation of Bosnia and Herzegovina region.
• European Centre for Disease Prevention and Control (ECDC)coreStrategic or Co-development PartnerActive participation in European disease surveillance and prevention networks.
• IFIC (International Association for Infection Control)coreStrategic or Co-development PartnerInternational cooperation in infection control and healthcare-associated infection prevention.
• FEMS (Federation of European Microbiological Societies)coreStrategic or Co-development PartnerActive membership in European microbiological societies for knowledge exchange and collaboration.
• Istanbul Memorial HospitalminorStrategic or Co-development PartnerCollaboration in endoscopy and transplant medicine with institutions abroad.
• Maryland Baltimore Military HospitalminorStrategic or Co-development PartnerInternational collaboration in medical specialties including transplant medicine.
• Bologna Medical InstitutionsminorStrategic or Co-development PartnerInternational collaboration in medical research and clinical practice.
• Kings College Hospital LondoncoreStrategic or Co-development PartnerCollaboration with one of the world's leading liver transplant centers for liver transplantation preparation and patient care.

Scale indicators17 records

Recent moves8 records

Expansion highlights5 records

Regional players

• Clinical Center of Vojvodina: Major public tertiary hospital in Novi Sad, Serbia, providing multi-specialty academic care. Comparable in scale and structure to KCUS as a public university hospital, though in a different country/health system.

Direct peers

• University Clinical Hospital Mostar: Public university teaching hospital in Mostar serving the Herzegovina-Neretva Canton. Directly comparable as a tertiary academic medical center in the Federation of Bosnia and Herzegovina, with similar specialty clinic structure and teaching-base affiliation.
• University Clinical Center Tuzla: The other major public university hospital in Bosnia and Herzegovina, providing secondary and tertiary care across Tuzla Canton. Directly comparable to KCUS in mission, ownership structure (FBiH government), and service mix, but smaller in scale and catchment.

Broad incumbents

• Acibadem Healthcare Group: Largest private hospital network in Turkey and the broader region, with growing presence in the Balkans. Comparable as a tertiary provider in the region, but represents the private-sector alternative to public academic centers like KCUS.
• University Clinical Center of Serbia: Largest public academic medical center in Serbia, providing the full range of tertiary services in Belgrade. Comparable as a regional public university hospital system, but substantially larger in scale and catchment population.
• Johns Hopkins Medicine: Global benchmark for academic medical centers combining research, teaching, and complex tertiary care. Relevant as a reference point for KCUS's academic/teaching-base model and translational research ambition, though vastly larger in scale and resources.
• University Medical Centre Ljubljana: Slovenia's largest public academic medical center, providing comprehensive tertiary care and serving as a teaching base. Comparable in role and structure to KCUS, but operates with EU funding and higher per-capita health spending.
• University Hospital Centre Zagreb: Croatia's flagship public university hospital, providing comprehensive tertiary care. Comparable in academic/teaching mission and specialty clinic breadth, but operates in a higher-income EU member state with materially larger budgets.
• Charité – Universitätsmedizin Berlin: One of Europe's largest university hospitals and a WHO collaborating center. Comparable as a public academic medical center with WHO reference roles, research partnerships, and specialty clinic breadth; relevant as the upstream partner for KCUS's Robert Koch/Francis Crick collaborations.

Others

• Institut Pasteur: International research institute and WHO collaborating center with which KCUS's microbiology unit partners through the MediLabSecure project. Relevant as an enabling/collaboration partner, not a direct competitor, but shapes KCUS's research positioning in infectious disease surveillance.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks7 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/KlinickiCentarUniverzitetaSarajevo
• LinkedInlinkedin.com/company/clinical-center-university-of-sarajevo
• Instagraminstagram.com/kcus.sarajevo?igsh=MTQydHRzbDcxenF0aw==

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Subsidiaries38 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Clinical center University of Sarajevo